BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

548 related articles for article (PubMed ID: 17907593)

  • 1. Marked elevation in homocysteine and homocysteine sulfinic acid in the cerebrospinal fluid of lymphoma patients receiving intensive treatment with methotrexate.
    Becker A; Vezmar S; Linnebank M; Pels H; Bode U; Schlegel U; Jaehde U
    Int J Clin Pharmacol Ther; 2007 Sep; 45(9):504-15. PubMed ID: 17907593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevation of homocysteine and excitatory amino acid neurotransmitters in the CSF of children who receive methotrexate for the treatment of cancer.
    Quinn CT; Griener JC; Bottiglieri T; Hyland K; Farrow A; Kamen BA
    J Clin Oncol; 1997 Aug; 15(8):2800-6. PubMed ID: 9256122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of intraventricular methotrexate on folate, adenosine, and homocysteine metabolism in cerebrospinal fluid.
    Quinn CT; Griener JC; Bottiglieri T; Arning E; Winick NJ
    J Pediatr Hematol Oncol; 2004 Jun; 26(6):386-8. PubMed ID: 15167354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of genetic variants of methionine metabolism with methotrexate-induced CNS white matter changes in patients with primary CNS lymphoma.
    Linnebank M; Moskau S; Jürgens A; Simon M; Semmler A; Orlopp K; Glasmacher A; Bangard C; Vogt-Schaden M; Urbach H; Schmidt-Wolf IG; Pels H; Schlegel U
    Neuro Oncol; 2009 Feb; 11(1):2-8. PubMed ID: 18806228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of infusion duration of high-dose methotrexate on cerebrospinal fluid drug levels in lymphoma patients].
    Lin XB; Zhou NN; Li S; Cai QQ; Xia ZJ; Liao H; Gao Y; Huang HQ
    Ai Zheng; 2008 Oct; 27(10):1100-5. PubMed ID: 18851792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methotrexate-associated alterations of the folate and methyl-transfer pathway in the CSF of ALL patients with and without symptoms of neurotoxicity.
    Vezmar S; Schüsseler P; Becker A; Bode U; Jaehde U
    Pediatr Blood Cancer; 2009 Jan; 52(1):26-32. PubMed ID: 19006245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute methotrexate-induced encephalopathy--causal relation to homozygous allelic state for MTR c.2756A>G (D919G)?
    Linnebank M; Malessa S; Moskau S; Semmler A; Pels H; Klockgether T; Schlegel U
    J Chemother; 2007 Aug; 19(4):455-7. PubMed ID: 17855192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent cognitive deficits, induced by intrathecal methotrexate, are associated with elevated CSF concentrations of excitotoxic glutamate analogs and can be reversed by an NMDA antagonist.
    Vijayanathan V; Gulinello M; Ali N; Cole PD
    Behav Brain Res; 2011 Dec; 225(2):491-7. PubMed ID: 21856332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carboxypeptidase G2 rescue after high-dose methotrexate.
    DeAngelis LM; Tong WP; Lin S; Fleisher M; Bertino JR
    J Clin Oncol; 1996 Jul; 14(7):2145-9. PubMed ID: 8683248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary central nervous system lymphoma: Phase I evaluation of infusional bromodeoxyuridine with whole brain accelerated fractionation radiation therapy after chemotherapy.
    Dabaja BS; McLaughlin P; Ha CS; Pro B; Meyers CA; Seabrooke LF; Wilder RB; Kyritsis AP; Preti HA; Yung WK; Levin V; Cabanillas F; Cox JD
    Cancer; 2003 Sep; 98(5):1021-8. PubMed ID: 12942571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical and clinical aspects of methotrexate neurotoxicity.
    Vezmar S; Becker A; Bode U; Jaehde U
    Chemotherapy; 2003 May; 49(1-2):92-104. PubMed ID: 12714818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is intrathecal methotrexate necessary in the treatment of primary CNS lymphoma?
    Khan RB; Shi W; Thaler HT; DeAngelis LM; Abrey LE
    J Neurooncol; 2002 Jun; 58(2):175-8. PubMed ID: 12164690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic drug monitoring of methotrexate in cerebrospinal fluid after systemic high-dose infusion in children: can the burden of intrathecal methotrexate be reduced?
    Niemann A; Mühlisch J; Frühwald MC; Gerss J; Hempel G; Boos J
    Ther Drug Monit; 2010 Aug; 32(4):467-75. PubMed ID: 20571463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined treatment with high-dose methotrexate, vincristine and procarbazine, without intrathecal chemotherapy, followed by consolidation radiotherapy for primary central nervous system lymphoma in immunocompetent patients.
    Ferreri AJ; Reni M; Dell'Oro S; Ciceri F; Bernardi M; Camba L; Ponzoni M; Terreni MR; Tomirotti M; Spina M; Villa E
    Oncology; 2001; 60(2):134-40. PubMed ID: 11244328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of transcobalamin c. 776C>G with overall survival in patients with primary central nervous system lymphoma.
    Linnebank M; Moskau S; Kowoll A; Semmler A; Bangard C; Vogt-Schaden M; Egerer G; Schackert G; Reichmann H; Schmidt-Wolf IG; Pels H; Schlegel U
    Br J Cancer; 2012 Nov; 107(11):1840-3. PubMed ID: 23099805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of chemotherapy additional to high-dose methotrexate for primary central nervous system lymphoma (PCNSL).
    Bergner N; Monsef I; Illerhaus G; Engert A; Skoetz N
    Cochrane Database Syst Rev; 2012 Nov; 11():CD009355. PubMed ID: 23152274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial.
    Thiel E; Korfel A; Martus P; Kanz L; Griesinger F; Rauch M; Röth A; Hertenstein B; von Toll T; Hundsberger T; Mergenthaler HG; Leithäuser M; Birnbaum T; Fischer L; Jahnke K; Herrlinger U; Plasswilm L; Nägele T; Pietsch T; Bamberg M; Weller M
    Lancet Oncol; 2010 Nov; 11(11):1036-47. PubMed ID: 20970380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of excitatory sulfur amino acids, cysteine sulfinic acid, cysteic acid, homocysteine sulfinic acid, and homocysteic acid in serum by stable isotope dilution gas chromatography-mass spectrometry and selected ion monitoring.
    Santhosh-Kumar CR; Deutsch JC; Kolhouse JC; Hassell KL; Kolhouse JF
    Anal Biochem; 1994 Aug; 220(2):249-56. PubMed ID: 7978266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homocysteine, pharmacogenetics, and neurotoxicity in children with leukemia.
    Kishi S; Griener J; Cheng C; Das S; Cook EH; Pei D; Hudson M; Rubnitz J; Sandlund JT; Pui CH; Relling MV
    J Clin Oncol; 2003 Aug; 21(16):3084-91. PubMed ID: 12915598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of pharmacokinetics and toxicity after high-dose methotrexate treatments in children with acute lymphoblastic leukemia.
    Csordas K; Hegyi M; Eipel OT; Muller J; Erdelyi DJ; Kovacs GT
    Anticancer Drugs; 2013 Feb; 24(2):189-97. PubMed ID: 23187460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.